Hypercalcemia of Malignancy Clinical Trial
Official title:
A Phase I/II, Single Arm, Open Label, Multi-center Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory Hypercalcemia of Malignancy
The purpose of this study is to determine the potential of JMT103 to treat hypercalcemia of malignancy in patients with elevated serum calcium who do not respond to recent treatment with intravenous bisphosphonates.
This is a Phase I/II, Single arm, Open Label, Multi-center Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With refractory Hypercalcemia of Malignancy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00060138 -
Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
|
Phase 1/Phase 2 | |
| Completed |
NCT00896454 -
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
|
Phase 2 | |
| Withdrawn |
NCT00301886 -
S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone
|
Phase 3 | |
| Terminated |
NCT00458796 -
Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone
|
N/A | |
| Withdrawn |
NCT01333267 -
One Week Comparison Study of PTH and PTHrP Infusions
|
Phase 1 | |
| Active, not recruiting |
NCT00326820 -
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
|
Phase 3 | |
| Completed |
NCT00003884 -
Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
|
Phase 3 |